Step-by-step support for memory and thinking problems in adults with brain metastases
Tests a tiered support program for thinking symptoms in adults with brain metastases.
Key facts
- Who runs it
- University Health Network, Toronto
- Where
- Canada1 site in 1 countryChoose a country to see its sites
- Trial code
- Registry title
- Feasibility of a Cognitive Stepped Care Program for Adults With Brain Metastases
- Status
- Recruiting
- People taking part
- 140 people, planned
- Started
- 9 Jan 2026
- Planned end
- Jun 2026
- Type of study
- Interventional
- Treatments tested
- Cognitive Stepped Care Program (CSCP)
- Record updated
- 21 January 2026
Who can take part
The trial is looking for adults with brain metastases (cancer that has spread to the brain) seen at the Brain Metastases Clinic. Their main caregivers and clinic staff can also join.
- Age
- 18 years or older
- Sex
- All
- Disease stage
- Patients: a brain metastasis from any primary cancer, receiving follow-up care in the Brain Metastases Clinic.
- Main reasons for not taking part
- Patients with a history of a significant developmental or learning disability or psychiatric disorder
- Patients with an acquired neurological disorder, such as traumatic brain injury
- Patients with poor ability to do daily activities (ECOG ≥ 3)
- Patients with life expectancy < 3 months
- People unable to speak, read and write in English, or unable to give written consent
Show the full registry criteria (19)Hide the full registry criteria
Who can take part
- Diagnosed with a brain metastasis for any primary cancer
- Receiving follow-up care in the Brain Metastases Clinic
- Adult (≥ 18 years)
- Able to speak, read, and write in English
- Able to provide written informed consent
- Self-identified or identified by consenting patient as a primary caregiver for a person with brain metastases receiving follow-up in the Brain Metastases Clinic
- Adult (≥ 18 years)
- Able to speak, read, and write in English
- Able to provide written informed consent
- Currently working as a clinician or administrative staff member in the Brain Metastases Clinic
- Adult (≥ 18 years)
- Able to speak, read, and write in English
- Able to provide written informed consent
Who cannot take part
- History of significant developmental/learning disability or psychiatric disorder, acquired neurological disorder (e.g., traumatic brain injury)
- Poor performance status (ECOG ≥ 3)
- Life expectancy < 3 months; Caregivers:
- N/A; Staff:
- N/A
Other criteria
- Patients:
Eligibility questionnaire
From the criteria published for this trial, to help you prepare for a talk with your doctor or the study team. We do not tell you a result. Only the study team can say whether you can take part.
- Age
- Brain metastases or brain metastasis
This trial is currently available in Canada.
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
Background: Cognitive symptoms are common and often severe in patients with brain metastases, significantly impacting their quality of life and ability to manage cancer care. Currently, there is no standard approach for routinely assessing and managing these symptoms in oncology clinics.
Read full original descriptionShow less
Objective: This study aims to evaluate the feasibility, acceptability, and preliminary efficacy of the Cognitive Stepped Care Program (CSCP) in a Brain Metastases Clinic.
Methods: This is a prospective, mixed-methods feasibility study involving patients with brain metastases, their caregivers, and clinic staff. Patients will undergo routine cognitive symptom screening using a standardized tool. Based on symptom severity, they will receive tiered interventions ranging from no support, to education materials, to computerized cognitive testing with individualized debrief, with group strategy training and/or neuropsychological consultation, as needed. Patients will complete questionnaires before and after the intervention regarding their symptoms and quality of life. Patients, caregivers and staff will provide their feedback about the intervention through questionnaires and interviews.
Outcomes: Primary outcomes include feasibility and acceptability of the CSCP. Secondary outcomes include preliminary changes in cognitive symptoms, self-efficacy, and quality of life.
Significance: This study will inform the potential integration of a structured cognitive support program into standard care for patients with brain metastases and may provide a model for similar interventions in other oncology settings.
The group in the trial
- Cognitive Stepped Care ProgramTreatment being tested
Treatment: Cognitive Stepped Care Program (CSCP)
Next steps
For your doctor
Doctor ask sheet
A PDF for your doctor: what this trial tests, who can take part, and 2 eligibility questions with room for answers and notes.
PDF, US Letter, 1 to 2 pages. A4 size
For the study team
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Codesign of a Cognitive Stepped Care Program (CSCP) to Enhance Quality of Life in Adults With Brain Metastases: Evaluation of Feasibility, Acceptability and Preliminary Efficacy
- Plain-language title
- Step-by-step support for memory and thinking problems in adults with brain metastasesGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 15 November 2026.
- Criteria questions
- Built from NCT07355348, who can take part
- Record updated
- 21 January 2026